Skip to content
Screener

BioSig Technologies, Inc. STEX Cash Flow Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
-$14.55M+28.6%-$46.69M-1,568%-$424.01M-38,481%-$15.58M-714%-$20.37M-421%
$1.47M+166%$1.49M+7,005%$1.47M+4,797%$1.49M+4,700%$554K+1,031%
$7.12M-41.3%$25.37M+1,123%$48.82M$12.12M+173%
-$11.74M-819%-$10.18M-813%-$3.02M-537%-$5.02M-237%-$1.28M+13.7%
-$1K
$10.66M-$1.5M-$24.47M
$11.34M$11.34M$11.34M
$2.01M$2.01M$2.01M
-$245K-$1.64M-135%$36.78M+3,677,900%$13.4M$0-100%
-$1.25M-$13.46M-475%$9.27M+2,060%$8.23M+652%$0-100%

FAQ

How much cash does BioSig Technologies, Inc. generate?
BioSig Technologies, Inc. (STEX) generated -$30.0M in operating cash flow over the trailing twelve months.
Where does BioSig Technologies, Inc.'s cash flow data come from?
Every line is extracted from BioSig Technologies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.